These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26085027)

  • 1. Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty.
    Arden N; Richette P; Cooper C; Bruyère O; Abadie E; Branco J; Brandi ML; Berenbaum F; Clerc C; Dennison E; Devogelaer JP; Hochberg M; D'Hooghe P; Herrero-Beaumont G; Kanis JA; Laslop A; Leblanc V; Maggi S; Mautone G; Pelletier JP; Petit-Dop F; Reiter-Niesert S; Rizzoli R; Rovati L; Tajana Messi E; Tsouderos Y; Martel-Pelletier J; Reginster JY
    Drugs Aging; 2015 Jul; 32(7):525-35. PubMed ID: 26085027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging biomarker validation and qualification report: sixth OARSI Workshop on Imaging in Osteoarthritis combined with third OA Biomarkers Workshop.
    Hunter DJ; Eckstein F; Kraus VB; Losina E; Sandell L; Guermazi A
    Osteoarthritis Cartilage; 2013 Jul; 21(7):939-42. PubMed ID: 23639411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Reginster JL; Arden NK; Haugen IK; Rannou F; Cavalier E; Bruyère O; Branco J; Chapurlat R; Collaud Basset S; Al-Daghri NM; Dennison EM; Herrero-Beaumont G; Laslop A; Leeb BF; Maggi S; Mkinsi O; Povzun AS; Prieto-Alhambra D; Thomas T; Uebelhart D; Veronese N; Cooper C
    Semin Arthritis Rheum; 2018 Aug; 48(1):1-8. PubMed ID: 29287769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of biomarkers in osteoarthritis: current status and perspectives.
    Lotz M; Martel-Pelletier J; Christiansen C; Brandi ML; Bruyère O; Chapurlat R; Collette J; Cooper C; Giacovelli G; Kanis JA; Karsdal MA; Kraus V; Lems WF; Meulenbelt I; Pelletier JP; Raynauld JP; Reiter-Niesert S; Rizzoli R; Sandell LJ; Van Spil WE; Reginster JY
    Ann Rheum Dis; 2013 Nov; 72(11):1756-63. PubMed ID: 23897772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Honvo G; Bannuru RR; Bruyère O; Rannou F; Herrero-Beaumont G; Uebelhart D; Cooper C; Arden N; Conaghan PG; Reginster JY; Thomas T; McAlindon T
    Drugs Aging; 2019 Apr; 36(Suppl 1):145-159. PubMed ID: 31073927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.
    Bruyère O; Cooper C; Arden N; Branco J; Brandi ML; Herrero-Beaumont G; Berenbaum F; Dennison E; Devogelaer JP; Hochberg M; Kanis J; Laslop A; McAlindon T; Reiter S; Richette P; Rizzoli R; Reginster JY
    Drugs Aging; 2015 Mar; 32(3):179-87. PubMed ID: 25701074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Hiligsmann M; Cooper C; Guillemin F; Hochberg MC; Tugwell P; Arden N; Berenbaum F; Boers M; Boonen A; Branco JC; Maria-Luisa B; Bruyère O; Gasparik A; Kanis JA; Kvien TK; Martel-Pelletier J; Pelletier JP; Pinedo-Villanueva R; Pinto D; Reiter-Niesert S; Rizzoli R; Rovati LC; Severens JL; Silverman S; Reginster JY
    Semin Arthritis Rheum; 2014 Dec; 44(3):271-82. PubMed ID: 25086470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for osteoarthritis: current position and steps towards further validation.
    Hunter DJ; Nevitt M; Losina E; Kraus V
    Best Pract Res Clin Rheumatol; 2014 Feb; 28(1):61-71. PubMed ID: 24792945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of osteoarthritis: challenges of model selection and analysis.
    Teeple E; Jay GD; Elsaid KA; Fleming BC
    AAPS J; 2013 Apr; 15(2):438-46. PubMed ID: 23329424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.
    Ladang A; Beaudart C; Reginster JY; Al-Daghri N; Bruyère O; Burlet N; Cesari M; Cherubini A; da Silva MC; Cooper C; Cruz-Jentoft AJ; Landi F; Laslop A; Maggi S; Mobasheri A; Ormarsdottir S; Radermecker R; Visser M; Yerro MCP; Rizzoli R; Cavalier E
    Calcif Tissue Int; 2023 Feb; 112(2):197-217. PubMed ID: 36633611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint and bone assessment in hand osteoarthritis.
    Ramonda R; Frallonardo P; Musacchio E; Vio S; Punzi L
    Clin Rheumatol; 2014 Jan; 33(1):11-9. PubMed ID: 24101035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoarthritis year 2012 in review: biomarkers.
    Mobasheri A
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1451-64. PubMed ID: 22842200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to define responders in osteoarthritis.
    Cooper C; Adachi JD; Bardin T; Berenbaum F; Flamion B; Jonsson H; Kanis JA; Pelousse F; Lems WF; Pelletier JP; Martel-Pelletier J; Reiter S; Reginster JY; Rizzoli R; Bruyère O
    Curr Med Res Opin; 2013 Jun; 29(6):719-29. PubMed ID: 23557069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New horizons in osteoarthritis.
    Wenham CY; Conaghan PG
    Age Ageing; 2013 May; 42(3):272-8. PubMed ID: 23568255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of hand osteoarthritis.
    Lennerová T; Pavelka K; Šenolt L
    Rheumatol Int; 2018 May; 38(5):725-735. PubMed ID: 29098370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoarthritis phenotypes and novel therapeutic targets.
    Van Spil WE; Kubassova O; Boesen M; Bay-Jensen AC; Mobasheri A
    Biochem Pharmacol; 2019 Jul; 165():41-48. PubMed ID: 30831073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New horizons in osteoarthritis.
    Oliviero F; Ramonda R; Punzi L
    Swiss Med Wkly; 2010; 140():w13098. PubMed ID: 20458653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.
    Kraus VB; Burnett B; Coindreau J; Cottrell S; Eyre D; Gendreau M; Gardiner J; Garnero P; Hardin J; Henrotin Y; Heinegård D; Ko A; Lohmander LS; Matthews G; Menetski J; Moskowitz R; Persiani S; Poole AR; Rousseau JC; Todman M;
    Osteoarthritis Cartilage; 2011 May; 19(5):515-42. PubMed ID: 21396468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis.
    Yu D; Xu J; Liu F; Wang X; Mao Y; Zhu Z
    Clin Exp Rheumatol; 2016; 34(5):929-934. PubMed ID: 27606839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis.
    Nguyen LT; Sharma AR; Chakraborty C; Saibaba B; Ahn ME; Lee SS
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.